Acquirer Profile
Cyclerion Therapeutics Acquisitions & Deals (2026)
biotechnology
Deals tracked
2
Combined value
$760M
Primary sector
biotechnology
Active
2026
FireStrike tracks every Cyclerion Therapeutics acquisition, merger, and strategic investment in real time. This page covers 2 Cyclerion Therapeutics deals totaling $760M in disclosed deal value, spanning biotechnology. Data covers 2026.
Cyclerion Therapeutics Acquisitions — Full List
| Target company | Announced | Source |
|---|---|---|
Korsana Biosciences, Inc. biotechnology | Apr 2026 | |
Korsana Biosciences biotechnology | Apr 2026 |
Cyclerion Therapeutics Acquisitions — FAQ
How many acquisitions has Cyclerion Therapeutics made?
Cyclerion Therapeutics has made 2 acquisitions and deals tracked on FireStrike, totaling $760M in combined deal value.
What sectors does Cyclerion Therapeutics acquire in?
Cyclerion Therapeutics primarily acquires in biotechnology.
What is Cyclerion Therapeutics's most recent acquisition?
Cyclerion Therapeutics's most recent tracked acquisition is Korsana Biosciences, Inc. for $380M, announced Apr 2026.
Get every Cyclerion Therapeutics deal in your inbox
FireStrike tracks M&A, IPOs, and fundraises daily — free.
Start tracking free →